STOCK TITAN

High Tide Announces Preliminary Q3 2026 Guidance

(Neutral)
(Positive)
Tags

High Tide (Nasdaq/TSXV: HITI) issued preliminary guidance for its third fiscal quarter ended July 31, 2026, forecasting record revenue of C$195–C$200 million, implying 9–12% sequential and 30–34% year-over-year growth. Expected gross profit is C$51–C$53.5 million, up 5–11% sequential and 27–33% year over year.

Adjusted EBITDA is guided to C$15.2–C$16.5 million, implying 9–19% sequential and 43–55% year-over-year growth. According to High Tide, even the low end of guidance is above the highest current analyst estimate for revenue, gross profit and Adjusted EBITDA. The company also reports a record quarterly distribution of over 10 tonnes of medical cannabis flower via Remexian Pharma in Germany, up 33% sequentially and 60% year over year, and notes a return to positive year-over-year same-store sales growth in its Canadian bricks-and-mortar network in June and July. Full Q3 2026 results are expected on September 14, 2026.

Loading...
Loading translation...

Positive

  • Q3 2026 revenue guidance C$195–C$200 million, +30–34% year over year
  • Gross profit guidance C$51–C$53.5 million, +27–33% year over year
  • Adjusted EBITDA guidance C$15.2–C$16.5 million, +43–55% year over year
  • Guidance low end exceeds highest analyst estimate across all three metrics
  • Remexian distributed 10+ tonnes of medical cannabis, +33% sequential, +60% year over year
  • Canadian bricks-and-mortar returned to positive year-over-year same-store sales in June and July

Negative

  • None.

News Explained

Adjusted EBITDA in the guidance is a supplemental non-IFRS measure without a standardized IFRS meaning, making it unlikely to be comparable with similarly named measures from other issuers.

Market Reaction – HITI

+5.58% $2.27
15m delay
+5.58% Vs previous close
$2.27 Last Price
$2.11 $2.27 Day Range
$196.68M Market Cap
0.1x Rel. Volume

Following this news, HITI has gained 5.58%, reflecting a notable positive market reaction. Our momentum scanner has triggered 4 alerts so far, indicating moderate trading interest and price volatility. The stock is currently trading at $2.27.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Market Context

Historical Q2 2026 earnings event 1070796 recorded a 12% 24-hour move. That platform record frames t...
Analysis

Historical Q2 2026 earnings event 1070796 recorded a 12% 24-hour move. That platform record frames this preliminary guidance as another operating milestone, while no recent insider activity provides no transaction signal; final Q3 results remain the key checkpoint.

Key Figures

Revenue guidance: C$195.0M-C$200.0M Gross profit guidance: C$51.0M-C$53.5M Adjusted EBITDA guidance: C$15.2M-C$16.5M +5 more
8 metrics
Revenue guidance C$195.0M-C$200.0M Q3 2026 management guidance
Gross profit guidance C$51.0M-C$53.5M Q3 2026 management guidance
Adjusted EBITDA guidance C$15.2M-C$16.5M Q3 2026 management guidance
Revenue year-over-year growth 30%-34% Q3 2026 guidance range
Gross profit year-over-year growth 27%-33% Q3 2026 guidance range
Adjusted EBITDA year-over-year growth 43%-55% Q3 2026 guidance range
Medical cannabis distribution Over 10 tonnes Record quarterly distribution through Remexian Pharma GmbH
Sequential distribution increase 33% Remexian medical cannabis distribution

Historical Context

5 past events · Latest: Jul 23 (Positive)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Jul 23 Store opening Positive +0.0% New Ottawa store expanded Canna Cabana’s Canadian retail footprint.
Jul 15 Shareholder AMA Neutral -1.8% CEO hosted a Reddit AMA covering strategy, operations, and outlook.
Jul 06 Rights plan adoption Neutral -1.3% Company approved temporary and amended shareholder rights plans.
Jun 17 Distribution partnerships Positive -6.0% Remexian showcased Canadian medical cannabis brand partnerships in Germany.
Jun 15 Q2 earnings report Positive +12.0% Record revenue and adjusted EBITDA exceeded the prior quarter’s results.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Operational news has produced mixed outcomes, with the prior earnings release aligning positively while several other announcements diverged from price direction.

Key Terms

adjusted ebitda, non-ifrs, same-store sales
3 terms
adjusted ebitda financial
"The Company Expects Record Revenue, Gross Profit and Adjusted EBITDA"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
non-ifrs financial
"This measure does not have a standardized meaning prescribed by International Financial Reporting Standards"
Non-IFRS refers to financial measures that companies report outside the standard accounting rules set by the International Financial Reporting Standards; these figures exclude or adjust certain items such as one-time costs, stock-based pay, or restructuring charges. Investors care because non-IFRS numbers try to show the business’s underlying performance — like a chef presenting a dish with optional toppings removed to highlight the core flavor — but they can be shaped to look more favorable, so compare them with the official IFRS statements.
same-store sales financial
"our bricks-and-mortar business returned to positive year-over-year same-store sales"
Same-store sales measure the revenue generated by stores that have been open for a certain period, typically a year, comparing their sales over different time frames. It helps assess whether a business is growing due to increased customer activity at existing locations rather than new stores. For investors, this figure indicates the health and performance of a company's core operations, independent of expansion efforts.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

The Company Expects Record Revenue, Gross Profit and Adjusted EBITDA Ahead of Analyst Forecasts

The Company Also Announces Record Quarterly Distribution of Over 10 Tonnes of Medical Cannabis Flower Through Remexian Pharma GmbH, Further Accelerating its German Market Position

High Tide Inc., August 4, 2026

CALGARY, AB, Aug. 4, 2026 /PRNewswire/ -- High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased to release guidance estimates regarding anticipated results for its third fiscal quarter ended July 31, 2026.


Management Guidance
Range (C$, MM)


Implied Sequential
Change


Implied Year Over
Year Change


Analyst Expectations1 (C$, MM)


Low

High


Low

High


Low

High


Low

Consensus

High

Revenue

$195.0

$200.0


9 %

12 %


30 %

34 %


$180.8

$183.4

$185.3

Gross Profit

$51.0

$53.5


5 %

11 %


27 %

33 %


$49.1

$49.3

$49.7

Adjusted EBITDA2

$15.2

$16.5


9 %

19 %


43 %

55 %


$13.0

$14.0

$14.4

1 Based on FactSet as at August 3, 2026.

2 Adjusted Earnings before interest, taxes, depreciation, and amortization ("EBITDA"). This measure does not have a standardized meaning prescribed by International Financial Reporting Standards ("IFRS") and is, therefore, unlikely to be comparable to similar measures presented by other issuers. Non-IFRS measures provide investors with a supplemental measure of the Company's operating performance, and therefore, highlight trends in the Company's core business that may not otherwise be apparent when relying solely on IFRS measures. Management uses non-IFRS measures in measuring the financial performance of the Company.

"This quarter's guidance demonstrates the growing earnings power of the global platform we have built. We expect to set new company records for revenue, gross profit and Adjusted EBITDA, with year-over-year growth of at least 30%, 27% and 43%, respectively. Importantly, even the low end of our guidance exceeds the highest current analyst estimate across all three metrics. We believe this provides clear evidence that current market expectations have not yet caught up with the strength, scale and operating leverage of our business," said Raj Grover, Founder and Chief Executive Officer of High Tide.

"Our performance is being driven by two increasingly powerful growth engines. In Canada, our bricks-and-mortar business returned to positive year-over-year same-store sales in June and remained positive in July, which we believe compares favourably with broader market trends and reinforces the resilience of our discount-club model. In Germany, Remexian achieved another all-time quarterly distribution record, shipping over 10 tonnes of medical cannabis, an increase of 33% sequentially, 60% year over year. Together, these results demonstrate that our Canadian retail platform is strengthening while our German medical cannabis business is scaling rapidly, creating a more diversified and increasingly profitable global enterprise," added Mr. Grover.

The Company anticipates releasing full financial and operational results for the third fiscal quarter ended July 31, 2026, on Monday, September 14, 2026, after markets close, with a conference call the following morning.

ABOUT HIGH TIDE

High Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:

Retail: Canna Cabana™ is the largest cannabis retail chain in Canada, with 229 domestic and 1 international location. The Company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products. In 2025, the Company became the first North American cannabis operator to launch a bricks-and-mortar presence in Germany.

Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company, with a 14% share of the German medical cannabis market, built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 22 countries including Canada.

High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange (the "TSXV") in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

CONTACT INFORMATION

Media Inquiries
Omar Khan
Chief Communications and Public Affairs Officer
High Tide Inc.
omar@hightideinc.com
403-770-3080

Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.com

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This news release contains "forward-looking information" and "forward-looking statements" within the meaning of applicable securities laws (collectively, "forward-looking statements"). Forward-looking statements are often, but not always, identified by words such as "expect", "intend", "plan", "believe", "anticipate", "estimate", "may", "will", "could", "should" and similar expressions. Forward-looking statements in this news release include, without limitation, statements relating to: continued strength and momentum of the Company; the Company reporting revenue, Adjusted EBITDA, same-store sales during the quarter, and volume distributed in line with the expectations outlined herein; the results being above analyst expectations; the date and time of the release of the Company's third fiscal quarter ended July 31, 2026 results and their webcast and conference to discuss the results thereof.

Forward-looking statements are based on management's current expectations and assumptions as of the date of this news release. Forward-looking statements are subject to risks, uncertainties and other factors that may cause actual results to differ materially, including, without limitation: delays or inability to obtain required regulatory approvals or authorizations; changes in competitive, market or consumer conditions; operational risks associated with opening and operating new stores; and the other risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

High Tide Inc. Logo

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-announces-preliminary-q3-2026-guidance-302841825.html

SOURCE High Tide Inc.

FAQ

What is High Tide’s (HITI) Q3 2026 revenue guidance?

High Tide guides Q3 2026 revenue to C$195–C$200 million. This implies 9–12% sequential growth and 30–34% year-over-year growth, according to High Tide, and is above the current analyst consensus range listed from FactSet as of August 3, 2026.

How does High Tide’s Q3 2026 guidance compare to analyst expectations for HITI?

According to High Tide, the low end of its Q3 2026 guidance exceeds the highest analyst estimate for revenue, gross profit and Adjusted EBITDA. FactSet consensus showed lower expectations, with revenue estimates between C$180.8 million and C$185.3 million as of August 3, 2026.

What is High Tide’s Q3 2026 Adjusted EBITDA guidance for HITI shareholders?

High Tide expects Q3 2026 Adjusted EBITDA of C$15.2–C$16.5 million. This implies 9–19% sequential and 43–55% year-over-year growth, according to High Tide, and is above the analyst consensus range of C$13.0–C$14.4 million reported from FactSet.

How did Remexian Pharma’s German medical cannabis distribution perform in Q3 2026 for High Tide (HITI)?

Remexian Pharma distributed over 10 tonnes of medical cannabis flower in Q3 2026. According to High Tide, this was an all-time quarterly record, representing 33% sequential growth and 60% year-over-year growth, supporting the company’s expanding German medical cannabis market position.

When will High Tide (HITI) release full Q3 2026 financial results?

High Tide plans to release full financial and operational results for Q3 2026 on Monday, September 14, 2026, after markets close. According to High Tide, a conference call to discuss the quarter is scheduled for the following morning for investors and analysts.

What gross profit does High Tide forecast for Q3 2026 and how is it changing?

High Tide guides Q3 2026 gross profit to C$51–C$53.5 million. This represents 5–11% sequential and 27–33% year-over-year growth, according to High Tide, and exceeds the analyst gross profit expectations, which ranged between C$49.1 million and C$49.7 million.